Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

Active Cases

0

Pending Settlement

1

Closed

1

Total Settlement

$44M

IMMUNOMEDICS INC (IMMU) Class Action Lawsuit (December 2018)Pending Settlement

2:18cv17645 • December 27, 2018

Class Period Start

February 8, 2018

Class Period End

April 17, 2019

PSLRA Deadline

February 25, 2019

Case Allegations

10b5

Statutes of Repose

Feb 8, 2021

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

June 8, 2023

Settlement Fund

$40,000,000

Settlement Status

Final Approval

Settlement Class

All persons or entities that purchased or otherwise acquired Immunomedics common stock during the period between February 9, 2018 and January 17, 2019, inclusive.

Claim Administrator

JND Legal Administration
Immunomedics Securities Settlement Claims Administrator c/o JND Legal Administration P.O. Box 91456 Seattle, WA 98111
+1 855-678-0183
[email protected]

Hearing Date

June 15, 2019

Opt-out Deadline

May 25, 2023

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Jun 15, 2023

Final Approval of Settlement

Feb 23, 2023

Preliminary Approval of Settlement

Feb 22, 2023

Proof of Claim Form

Feb 22, 2023

Jan 20, 2023

Proposed Settlement

Jun 2, 2022

Motion for Class Certification

Apr 11, 2022

Scheduling Order

Feb 10, 2022

Scheduling Order

Oct 12, 2021

Scheduling Order

Jul 19, 2021

Second Amended Complaint

Feb 26, 2021

Scheduling Order

Dec 8, 2020

Scheduling Order

Oct 9, 2020

Scheduling Order

Sep 18, 2020

Scheduling Order

Aug 10, 2020

Scheduling Order

Aug 4, 2020

Scheduling Order

Jul 31, 2020

Motion to Dismiss Denied

Jan 17, 2020

Motion to Dismiss

Dec 4, 2019

Scheduling Order

Nov 18, 2019

First Amended Complaint

Oct 7, 2019

Scheduling Order

Sep 10, 2019

Appointment of Lead Plaintiff

Mar 21, 2019

Scheduling Order

Feb 8, 2019

Additional Complaint (Change in CP)

Dec 27, 2018

First Filed Complaint

IMMUNOMEDICS INC (IMMU) Class Action Lawsuit (December 1969)Closed

2:16cv3335 • June 9, 2016

Class Period Start

May 1, 2016

Class Period End

September 23, 2016

PSLRA Deadline

August 8, 2016

Case Allegations

10b5

Statutes of Repose

May 1, 2019

Country

United States

Court

Federal Court

Docket History

May 30, 2023

Disbursement Approved

Jan 19, 2023

Final Approval of Settlement

Oct 5, 2022

Oct 5, 2022

Proof of Claim Form

Oct 5, 2022

Preliminary Approval of Settlement

Apr 14, 2022

Proposed Settlement

Oct 8, 2020

Scheduling Order

Jun 15, 2020

Scheduling Order

Jun 1, 2020

Motion to Dismiss Denied

Jul 10, 2019

Scheduling Order

Jul 2, 2019

Motion to Dismiss

Jun 6, 2019

Second Amended Complaint

Jun 3, 2019

Second Amended Complaint

May 30, 2019

Second Amended Complaint

Apr 24, 2019

Scheduling Order

Mar 31, 2019

Motion to Dismiss Granted

Jan 26, 2018

Motion to Dismiss

Oct 4, 2017

Feb 7, 2017

Appointment of Lead Plaintiff

Jun 9, 2016

First Filed Complaint

TOP